Related Experiment Video

Updated: May 2, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

9.8K

Postcraniofacial trauma multidrug resistant Acinetobacter baumannii infection treated with intravenous colistin: a

Sanjay Rastogi1, Anurag Gupta, Raja S Narne

  • 1Department of Oral and Maxillofacial Surgery and Oral Implantology, ITS Dental College, Murad Nagar, India.

Indian Journal of Dental Research : Official Publication of Indian Society for Dental Research
|February 21, 2014
PubMed

Insights

Nosocomial meningitis from multidrug-resistant Acinetobacter baumannii is a rare but serious risk following craniofacial trauma. Successful treatment with colistin highlights the need for infection control and prompt antibiotic use.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Neurosurgery

Background:

  • Nosocomial meningitis is a rare but severe complication following craniofacial and neurosurgical procedures.
  • The rise of multidrug-resistant (MDR) Acinetobacter baumannii presents significant treatment challenges for bacterial meningitis.

Observation:

  • A 52-year-old male with complex craniofacial trauma developed a nosocomial wound infection with MDR Acinetobacter baumannii.
  • The patient was identified as being at high risk for developing meningitis due to the nature of his injury and infection.

Findings:

  • The patient successfully received treatment for the MDR Acinetobacter baumannii infection with intravenous colistin.
  • This case demonstrates the successful management of a complex infection in a high-risk patient.

Implications:

  • Patients with complex maxillofacial trauma are particularly vulnerable to MDR Acinetobacter baumannii meningitis.
  • Implementing robust infection control measures and appropriate antibiotic strategies is crucial in craniofacial intensive care units to mitigate this risk.

More Related Videos

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging09:29

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

Published on: April 28, 2017

8.6K
Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

1.3K

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
842
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial...
21
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K